New point of attack for breast cancer with poor prognosis
(Medical Xpress) -- Scientists from the Friedrich Miescher Institute for Biomedical Research describe how the protein phosphatase SHP2 promotes breast cancer with poor prognosis. As they report in the latest issue of Nature Medicine, SHP2 is necessary for the maintenance of the few tumor initiating cells (TICs) in a breast tumor. These cells are thought to sustain the growth of the tumor, promote metastasis and lead to relapses.
A few cells can wreak deadly havoc. This population of cells can not only initiate cancer, it may, in some tumor types, also be the one to promote growth, resist therapy, or cause relapse. In recent years, these so-called tumor initiating cells (TICs) have thus moved into the focus of attention because of their promise for therapeutic intervention: TICs seem to be the reason why patients with some cancers do not react to therapy or relapse quickly after remission, and TICs seem to be more abundant in aggressive and refractory cancers. Unfortunately, knowledge about the signaling pathways controlling the functions of TICs is only starting to become available.
The fundamental role of SHP2
In a breast cancer study, Mohamed Bentires-Alj and scientists from his group at the Friedrich Miescher Institute for Biomedical Research identified now an important player in the signaling cascades governing TICs. The protein phosphatase SHP2 plays a fundamental role in breast cancer proliferation, invasion and metastasis. When the scientists depleted SHP2 from breast cancer cells with a small hairpin RNA, it decreased proliferation and invasiveness in 3D cultures, blocked tumor growth and reduced metastasis. What is more they showed in a xenograft model that SHP2 depletion eradicated TICs as well. "We believe that one should not only target the bulk of the tumor but also the tumor initiating cells," comments Bentires-Alj. "By better understanding the signaling events governing tumor initiating cells, we hope to develop new, more efficacious, therapeutic approaches."
Labeled for invasive behavior and poor prognosis
When looking at the molecular signaling events after SHP2 depletion, the scientists realized that SHP2 activates transcription factors that are usually associated with stem cells. Together with Michael Stadler, the head of bioinformatics at the FMI, they further identified what they called "signature genes" that are being co-overexpressed in the presence of SHP2. These genes are activated in a large subset of primary breast tumors associated with invasive behavior and poor prognosis.
"The discovery of the gene signature which is induced by SHP2 in breast tumors may provide an important readout for SHP2 activity, thus allowing the identification of tumors that are likely to respond to SHP2-targeted therapy," said Nicola Aceto, first author of the publication.
"Now that we have elucidated the critical role SHP2 plays in tumor initiating cells, we are eager to see our basic research findings translated into effective therapies. To this end selective inhibitors should be developed and tested. In general, our understanding of cancer over the last decades holds promises for better therapies. It is thus very important that basic scientists, industry and clinicians work together to help these to bear fruit," said Bentires-Alj.
More information: Aceto N, et al. (2012) Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop. Nature Medicine, doi:10.1038/nm.2645
Journal reference: Nature Medicine
Provided by Friedrich Miescher Institute for Biomedical Research
- New breast cancer model of mutant PI3K recapitulates features of human breast cancer Jul 12, 2011 | not rated yet | 0
- Protein is key to embryonic stem cell differentiation Mar 18, 2009 | not rated yet | 0
- Antibiotic offers potential for anti-cancer activity Jan 28, 2011 | not rated yet | 0
- A gene that fights cancer, but causes it too May 16, 2011 | not rated yet | 0
- New functional understanding outlines therapy for untreatable breast cancer Mar 07, 2011 | not rated yet | 0
- Motion perception revisited: High Phi effect challenges established motion perception assumptions Apr 23, 2013 | 3 / 5 (2) | 2
- Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update) Apr 02, 2013 | 4.5 / 5 (11) | 5
- The visual system as economist: Neural resource allocation in visual adaptation Mar 30, 2013 | 5 / 5 (2) | 9
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013 Hi, Is it because around central vein, there is only deoxygenated blood from the vein where as in the periphery there is hepatic artery. Also why...
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013 As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
- More from Physics Forums - Medical Sciences
More news stories
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer 22 hours ago | not rated yet | 0
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer 22 hours ago | 5 / 5 (1) | 0
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer May 24, 2013 | 5 / 5 (1) | 0
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer May 24, 2013 | 5 / 5 (2) | 0
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer May 24, 2013 | 5 / 5 (4) | 0
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
4 hours ago | 5 / 5 (1) | 4
Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.
22 hours ago | 3.7 / 5 (3) | 3 |
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
4 hours ago | not rated yet | 1
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
20 hours ago | 3 / 5 (2) | 0 |
Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...
23 hours ago | 5 / 5 (5) | 0 |
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
4 hours ago | not rated yet | 0